Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
to determine the efficacy of telaprevir administered as 750 mg every 8 hours (q8h) in combination with pegylated interferon (Peg-IFN)-alfa-2a and ribavirin (RBV) in genotype 1 chronic HCV infected liver transplant patients as measured by sustained virologic response (SVR12planned). SVR12planned is defined as having HCV ribonucleic <25 IU/mL acid (RNA) level 12 weeks after the last planned dose of study medication.
Critère d'inclusion
- Chronic Hepatitis C Infection